| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Operations & Product Dvlp. | VP Prod Dev | VP Operations & Prod Dev
1 company
Christal M M Mickle last filed a Form 4 in January 2024, as VP, Operations & Product Dvlp. at ZVRA. Christal M M Mickle's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 159,550 shares of ZVRA. Net of sales, the ZVRA filings show accumulation of 9,450 shares.
Christal M M Mickle has 10 Form 4 filings on record from April 2015 to January 2024, all as Chief Development Officer at Zevra Therapeutics (ZVRA), 2015–2024.
The 23 reported transactions were 8 option or other derivative awards, 8 gifts, 4 open-market purchases and 2 conversions, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $69K and no sales.
The largest open-market purchase was 2,450 shares of ZVRA at an average $14.57 on March 29, 2016, about $36K.
Shares as reported in the last Form 4 for each company; the most recent is from January 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 22, 2017 | ZVRA Zevra Therapeutics, Inc. | VP, Operations & Product Dvlp. | Buy | 2,000 | $4.10 | $8,199.00 | +28.4% | |
| Aug 17, 2016 | ZVRA Zevra Therapeutics, Inc. | VP Prod Dev | Buy | 5,000 | $4.95 | $24,750.00 | +243.9% | |
| Mar 29, 2016 | ZVRA Zevra Therapeutics, Inc. | VP Prod Dev | Buy | 2,450 | $14.57 | $35,703.30 | -612.5% |